Cancer research at risk as U.S. moves threaten cross-border funding

Proposed funding cuts and tariffs in the United States are raising concerns among cancer researchers in Canada. The Canadian Cancer Society (CCS) says these changes could impact local research efforts that rely on U.S. support, just as it launches its annual Daffodil Month fundraising campaign.

In 2024, Canadian research projects received over $40 million USD from the U.S. National Institutes of Health (NIH), but a recent CCS survey found 72% are worried about how U.S. tariffs could affect their work, and 78% are concerned about potential cuts to American funding for joint research.

As such, CCS is renewing calls for public support as cancer remains one of the most pressing health challenges in the country. Every three minutes, someone in Canada receives a cancer diagnosis. Although survival rates have improved significantly over the decades—with five-year survival now at 64% compared to 25% in the 1940s—researchers say that progress depends on continued investment.

“Changes happening south of the border are having ripple effects on cancer research in Canada. Our sustained investment in cancer research is essential. It's lifesaving. Without sufficient funding, research momentum will stall, and promising treatments may be delayed by years—time that not every person diagnosed with cancer has,” CCS CEO Andrea Seale said.

For Roy Jackson, a physician from White Rock, B.C., advances in cancer research have played a crucial role in his ongoing treatment. Now facing stage four melanoma, Jackson is receiving care informed by genetic testing that wasn’t available when he was first diagnosed with stage one melanoma in 2012.

“I want more people to know about the heroes of the Canadian cancer care system – researchers and innovators—without whom I wouldn't be alive. These investments make all the difference. They're making a difference in my life today, and they start with supporting fundraising campaigns like Daffodil Month now,” Jackson said.

Money raised during Daffodil Month helps fund research and patient support programs, such as free rides to treatment and lodging for those who must travel for care.

“Daffodil Month is not just about raising funds; it's about our nation showing solidarity with those affected by cancer and ensuring they have access to the progress, treatments, and support they need. Together, we must ensure researchers in Canada can continue their work, for the benefit of everyone impacted by cancer,” Seale said.